Abstract
Management of low grade optic glioma in children and adolescents remains controversial. Treatment with chemotherapy may delay or eliminate the need for radiation therapy. Children with newly diagnosed optic chiasm glioma were eligible for enrollment in this phase II trial and received intravenous carboplatin (CBDCA) (560 mg/m2) every four weeks. Patients were monitored closely for toxicity and tumor status. Twelve children were enrolled. Six patients had stable disease, four a partial response and two progressed on therapy. Overall progression free survival was 83±11%. The median duration of follow-up was 38.6 months (range 18–63 months). No deaths were noted in our series. Thrombocytopenia was the major toxicity, and two patients required platelet transfusions. One child developed an urticarial reaction requiring discontinuation of therapy. Another child developed unilateral high frequency hearing loss. No renal toxicity was encountered. We have demonstrated that carboplatin can eliminate or delay radiation therapy in children and adolescents with low grade optic glioma. CBDCA deserves further investigation in larger clinical trials as a treatment for children with optic chiasm glioma.
Similar content being viewed by others
References
Listernick R, Charrow J, Greenwald M, Mets M: Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatr 125: 63–66, 1994
Listernick R, Carrow J, Greenwald MJ, Esterly NB: Optic gliomas in children with neurofibromatosis type 1. J Pediatr 114: 788–792, 1989
Bataini JP, Delanian S, Ponvert D: Chiasmal gliomas: results of irradiation management in 57 patients and review of literature. Int J Radiation Oncol Biol Phys 21: 615–623, 1991
Pierce SM, Barnes PD, Loeffler JS, McGinn C, Tarbell NJ: Definitive radiation therapy in the management of symptomatic patients with optic glioma. Cancer 65: 45–52, 1990
Packer RJ, Savino PJ, Bilaniuk LT, Zimmerman RA, Schatz NJ, Rosenstock JG, Nelson DS, Jarrett PD, Bruce DA, Schut L: Chiasmatic gliomas of childhood. A reappraisal of natural history and effectiveness of cranial irradiation. Child's Brain 10: 393–403, 1983
Packer RJ, Sutton LN, Bilaniuk LT, Radcliffe J, Rosenstock JG, Siegel KR, Bunin GR, Savino PJ, Bruce DA, Schut L: Treatment of chiasmal / hypothalamic gliomas of childhood with chemotherapy: an update. Ann Neurol23: 79–85, 1988
Rosenstock JG, Packer RJ, Bilaniuk L, Bruce DA, Radciffe JL, Savino P: Chiasmatic optic glioma treated with chemotherapy. A preliminary report. J Neurosurg 63: 862–866, 1985
Sumer T, Freeman AI, Cohen M, Bremer AM, Thomas PR, Sinks LF: Chemotherapy in recurrent noncystic low grade astrocytomas of childhood. Pediatr Neurosci 13: 98–107, 1978
Prados MD: Treatment strategies for patients with recurrent brain tumors. Semin Radiat Oncol 1: 62–68, 1991
Kornblith PL, Walker M: Chemotherapy for malignant gliomas. J Neurosurg 68: 1–17, 1988
Friedman HS, Krischer JP, Burger P, Oakes WJ, Hockenberger B, Weiner MD, Falletta JM, Norris D, Ragab AH, Mahoney DH, Whitehead MV, Kun LE: Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study. J Clin Oncol 10: 249–256, 1992
Gaynon PS, Ettinger LJ, Baum ES, Siegel SE, Krailo MD, Hammond GD: Carboplatin in childhood brain tumors-a children's cancer study group phase II trial. Cancer 66: 2465–2469, 1990
Packer RJ, Lange B, Ater J, Nicholson HS, Allen J, Walker R, Prados M, Jakacke R, Reaman G, Needles MN, Phillips PC, Ryan J, Boyett JM, Geyer R, Finlay J: Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Clin Oncol11: 850–856, 1993
Blatt I, Jaffe R, Deutsch M, Adkins JC: Neurofibromatosis and childhood tumors. Cancer 57: 1225–1229, 1986
Wisoff JH, Abbott R, Epstein F: Surgical management of exophytic chiasmatic-hypothalamic tumors of childhood. J Neurosurg 73: 661–667, 1990
Rappaport R, Brauner R: Growth and endocrine disorders secondary to cranial irradiation. Pedatr Res 25: 561–567, 1989
Duffner PK, Cohen ME: Isolated optic nerve glioma and the management of optic nerve tumours in the young. Br J Opthal 73: 967–974, 1988
Petronio J, Edwards MSB, Prados M, Freyberger S, Rabbitt J, Silver P, Levin VA: Management of chiasmal and hypothalamic gliomas of infancy and childhood with chemotherapy. J Neurosurg 74: 701–708, 1991
Packer RJ, Ater J, Allen J, Allen J, Phillips P, Geyer R, Nicholson HS, Jakacki R, Kurczynski E, Needle M, Finlay J, Reaman G, Boyett JM: Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 86: 747–754, 1997
Warnick RE, Prados MD, Mack EE, Chandler KL, Doz F, Rabbitt JE, Malec MK: A phase II study of intravenous carboplatin for the treatment of recurrent gliomas. J Neuro Oncol 19: 69–74, 1994
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Aquino, V.M., Fort, D.W. & Kamen, B.A. Carboplatin for the Treatment of Children with Newly Diagnosed Optic Chiasm Gliomas: A Phase II Study. J Neurooncol 41, 255–259 (1999). https://doi.org/10.1023/A:1006149809479
Issue Date:
DOI: https://doi.org/10.1023/A:1006149809479